Mar 30, 2026

Featuring perspectives from Prof Karim Fizazi and Dr Daniel George, moderated by Dr Elisabeth I Heath, including the following topics:

• Introduction (0:00)
• Clinical Implications of and Appropriate Strategies to Identify PTEN Deficiency in Prostate Cancer — Dr George (3:25)
• Targeting AKT in Metastatic Prostate Cancer...

Mar 28, 2026

Featuring perspectives from Ms Jamie Carroll, Prof Giuseppe Curigliano, Dr Marie E McDonnell and Dr Hope S Rugo, including the following topics:

• Introduction: Use of On-Body Glucose Monitoring Devices (0:00)
• Overview of Breast Cancer and Diabetes (9:39)
• PI3K/AKT/mTOR Pathway and Glucose Metabolism (19:28)
• Case...

Mar 27, 2026

Featuring patient case presentations by Dr Jacqueline T Brown and Dr Nazli Dizman, with commentary from Dr Matthew Milowsky, including the following topics:

• Case: A man in his mid 50s with metastatic recurrence of urothelial bladder cancer (UBC) after neoadjuvant cisplatin/gemcitabine receives first-line enfortumab...

Mar 26, 2026

Featuring perspectives from Dr Stacey A Cohen, Dr Christopher Lieu and Dr Jenny Seligmann, moderated by Dr Lieu, including the following topics:

• Neoadjuvant immunotherapy for localized rectal cancer (0:00)
• Surveillance in neoadjuvant immunotherapy for localized rectal cancer (8:14)
• Determining a treatment strategy for...

Mar 25, 2026

Featuring perspectives from Dr Matthew D Galsky, Dr Shilpa Gupta, Dr Terence Friedlander and Prof Andrea Necchi, moderated by Dr Friedlander, including the following topics:

• Introduction (0:00)
• Optimal Use of Anti-PD-1/PD-L1 Antibodies in Non-Muscle-Invasive Bladder Cancer — Dr Friedlander (2:27)
• Evolving Management...